CClinicalTrials.gg
CompletedNCT02477943AheadCASUpdated May 23, 2019

Objective Brain Function Assessment of mTBI/Concussion in College Athletes

An observational study in Brain Injuries, Traumatic, Concussion, Mild and Concussion, Brain, sponsored by BrainScope Company, Inc.. Completed at 11 sites in United States. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2019-05-23.

Sponsored by BrainScope Company, Inc. · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
520
Ages
18 Years to 25 Years
Sex
All
01

Study summary

This study (Part 1) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery. In addition, neuroimaging will be conducted at time of injury and following Return to Play (RTP).

Read the detailed description

Injured/concussed subjects will be studied at time of injury, and at 3 follow-up time points following injury. Matched controls will be tested following the same schedule as the injured athletes. In addition, the study will include an additional pool of contact and non-contact athletes who are not head injured and will be assessed prior to the season and then after the season has ended. This data will be used to populate a database for the purpose of deriving a multimodal concussion index.

02

Conditions studied

  • Brain Injuries, Traumatic
  • Concussion, Mild
  • Concussion, Brain
  • Concussion, Intermediate
  • Concussion, Severe

Keywords

  • Concussion
  • Mild Traumatic Brain Injury
  • Sport Related Concussion
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's enrollment of 520 is above the median of 100 across 690 observational studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

BrainScope Company, Inc. is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Approximately 450 male and female student-athletes from participating universities or colleges will be invited to participate.

Inclusion criteria

  • Concussion-Injury subjects will be defined as follows: Any player who, based on independent clinical impression, is suspected of having suffered a concussion of any severity level, and on whom a routine clinical examination for concussion or head injury would have been conducted prior to implementation of this research protocol according to current standard practice.

    1. If loss of consciousness, total duration less than \<20 minutes
    2. No evidence of abnormality visible on Computerized Tomography (CT) of the head related to the traumatic event (Note: neuroimaging is not required for enrollment)
    3. No hospital admission due to either head injury or collateral injuries for >24 hours.
    4. GCS is between 13-15.

Exclusion criteria

Exclusion Criteria:

  1. Evidence of illicit drug usage
  2. Do not speak or read English
  3. Current CNS active prescription medications, with the exception of medications being taken for the treatment of Attention Deficit Disorder (ADD)
  4. Skull abnormalities, e.g. metal plate
  5. History of brain surgery or neurological disease.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
520 participants (actual)
Patient registry
No

Groups and cohorts

  • Injured and Matched Control Subject Pool

    Injured subjects consist of athletes who are head injured and meet the inclusion/exclusion criteria. Injured subjects will be tested within 72 hours (3 days) of injury and at specified time points post injury. Matched control subjects will be tested at the same time intervals as the injured subject. BrainScope Battery will be performed at each time point and consists of the following components: brain electrical activity (EEG), neurocognitive performance assessment, balance/sway measurement, and clinical symptoms/assessments. In addition, a subset of injured and matched control subjects will receive advanced MRI/DTI neuroimaging at time of injury and following RTP.

    Device: BrainScope Ahead 200iD · Device: Advanced MRI Neuroimaging

  • Pre-Season and Post-Season Subject Pool

    This subject pool will consist of uninjured (not head injured) contact and non-contact athletes and will be tested at two time points - pre-season and post-season. These subjects will perform the same BrainScope Battery as the injured and matched control subjects at each time points.

    Device: BrainScope Ahead 200iD

Interventions

  • DeviceBrainScope Ahead 200iD

    The BrainScope Battery evaluation will consist of 4 tests to aid in the assessment of concussion: History, Physical, signs and symptoms (SAC, SCAT3), Electrophysiological Function; Neurocognitive Performance Assessment and a balance/sway measurement. BrainScope Ahead 200iD device will be used to perform EEG.

  • DeviceAdvanced MRI Neuroimaging

    Diffusion tensor imaging (DTI) is a magnetic resonance imaging technique that enables the measurement of the restricted diffusion of water in tissue in order to produce neural tract images instead of using this data solely for the purpose of assigning contrast or colors to pixels in a cross sectional image.

    Also known as: Magnetic Resonance Imaging, Diffusion Tension Imaging

06

What researchers measure

Primary outcomes

  1. Algorithm for Likelihood of being concussed

    Create a database of brain electrical activity (EEG) and clinical information collected from athletes who sustain a concussion during organized sports.

    Time frame: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP

Secondary outcomes

  1. Advanced Neuroimaging in concussion

    Exploration of changes in functional neuroimaging which occur with concussion and change in these measures over time.

    Time frame: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP

07

Study locations

11 sites
  • University of Arkansas
    Fayetteville, Arkansas 72701, United States
  • University of Connecticut
    Storrs, Connecticut 06269, United States
  • University of South Florida
    Tampa, Florida 33612, United States
  • Michigan State University
    East Lansing, Michigan 48824, United States
  • University of New Mexico
    Albuquerque, New Mexico 87106, United States
  • University of Rochester Medical Center
    Rochester, New York 14642, United States
  • SUNY Upstate Medical University
    Syracuse, New York 13210, United States
  • University of South Carolina
    Columbia, South Carolina 29208, United States
  • University of Texas - Austin
    Austin, Texas 78712, United States
  • Baylor College of Medicine
    Houston, Texas 77030, United States
  • Houston Methodist Hospital
    Houston, Texas 77030, United States
08

References and documents

Publications

  • Covassin T, McGowan AL, Bretzin AC, Anderson M, Petit KM, Savage JL, Katie SL, Elbin RJ, Pontifex MB. Preliminary investigation of a multimodal enhanced brain function index among high school and collegiate concussed male and female athletes. Phys Sportsmed. 2020 Nov;48(4):442-449. doi: 10.1080/00913847.2020.1745717. Epub 2020 Mar 31. PubMed 32228157 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02477943
Lead sponsor
BrainScope Company, Inc.
Collaborators
United States Department of Defense
Responsible party
Sponsor
First posted
Jun 23, 2015
Start date
Aug 8, 2015
Primary completion
Feb 20, 2017
Completion
Jul 31, 2017
Last update
May 23, 2019

Study contacts

Leslie Prichep, Ph.D.
study director · BrainScope Company, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion